Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Sorafenib × Clear all

NCT00107432 2013-06-05

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural